Join us on Sunday, May 17, 2026, in Orlando, FL or via live stream!

Program Description

Join us for a dynamic Mechanisms to Medicine symposium featuring expert panelists Drs. Joseph Han, Flavia Hoyte, and Nizar Jarjour as they examine evolving management approaches for epithelial cytokine–driven inflammatory diseases of the upper and lower airways. This program brings together multidisciplinary perspectives from pulmonology, allergy and immunology, and otorhinolaryngology to explore shared underlying disease mechanisms in asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and chronic obstructive pulmonary disease (COPD). 

The engaging faculty panel will guide participants through an examination of epithelial cytokine signaling in airway diseases and practical therapeutic decision-making involving new and emerging biologic therapies that target these shared upstream mechanisms. Through a focused Whiteboard animation, case-based checkpoints, and interactive faculty dialogue, learners will examine how epithelial alarmins such as thymic stromal lymphopoietin (TSLP), interleukin-25 (IL-25), and interleukin-33 (IL-33) drive inflammation, airway dysfunction, and disease persistence. 

Attendees will also learn about the latest clinical evidence for newer and emerging biologic therapies that target upstream epithelial cytokine signaling and discuss how to incorporate these novel therapies into mechanism-based treatment strategies, with an emphasis on optimizing disease control, reducing oral corticosteroid use, and improving outcomes across the unified airway.